Development
Bruker Corporation
BRKR
$34.54
$2.186.74%
NASDAQ
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 13.27% | 8.93% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 15.04% | 8.93% | |||
| Cost of Revenue | 17.05% | 5.28% | |||
| Gross Profit | 13.15% | 12.58% | |||
| SG&A Expenses | 15.91% | -0.34% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 112.50% | 220.00% | |||
| Total Operating Expenses | 17.23% | 3.36% | |||
| Operating Income | 4.81% | 45.61% | |||
| Income Before Tax | 102.26% | 53.80% | |||
| Income Tax Expenses | 20.45% | 54.77% | |||
| Earnings from Continuing Operations | 130.67% | 53.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 250.00% | 14.29% | |||
| Net Income | 133.26% | 54.29% | |||
| EBIT | 4.81% | 45.61% | |||
| EBITDA | 10.79% | 36.01% | |||
| EPS Basic | 135.01% | 54.50% | |||
| Normalized Basic EPS | 21.72% | 36.48% | |||
| EPS Diluted | 134.73% | 54.24% | |||
| Normalized Diluted EPS | 21.88% | 36.66% | |||
| Average Basic Shares Outstanding | -0.75% | -0.14% | |||
| Average Diluted Shares Outstanding | -0.88% | -0.27% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.58% | -0.34% | |||